INDRAPRASTHA MEDICAL CORP Intrinsic Value
INDRAMEDCO · Healthcare · Current price ₹358.05
Is INDRAPRASTHA MEDICAL CORP undervalued?
DocStoX estimates the fair value of INDRAPRASTHA MEDICAL CORP at ₹486 per share, versus the current market price of ₹358. That puts the stock about +35.6% below our fair-value estimate, which we read as "Buy". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 4 independent methods: Residual income (₹137), Relative P/E (₹1,296), Graham floor (₹191), Analyst target (₹550). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹137 (bear) to ₹486 (base) to ₹1,296 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Margin of safety
Value investors demand a margin of safety — a discount to intrinsic value that protects against being wrong. At ₹358 versus an intrinsic value of ₹486, INDRAPRASTHA MEDICAL CORP currently offers +35.6% of margin.
More on INDRAPRASTHA MEDICAL CORP
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.